Ishtiaq Khaliq

Company: UCB S.A.

Job title: Gene Therapy & Molecular Biology Sciences Lead

Seminars:

Technological Advances in Gene Therapy: Reducing Uncertainty in Dosing with dPCR 12:00 pm

Transition from qPCR to dPCR: Discuss how digital PCR (dPCR) has improved accuracy in measuring viral genome titers Dose Precision Improvements: Highlight the reduction in uncertainty from 50% to less than 15% using dPCR, allowing for more reliable dosing Impact on Gene Therapy Products: Explore how this innovation enhances understanding and quality control in gene…Read more

day: Conference Day One